Table of Contents Table of Contents
Previous Page  S289 S290 Next Page
Information
Show Menu
Previous Page S289 S290 Next Page
Page Background

CATEGORY: NEUROLOGICAL REHABILITATION

Poster 489:

Risk Factor Analysis and Practical Screening Protocol for Deep Vein

Thrombosis in Patients with Traumatic Spinal Cord Injuries on

Admission to Inpatient Rehab

Marc A. Raj, DO (LSU Health Med Cntr), Gary Glynn, LSU PM&R

Program Chair, Eric F. Sterne, MD, Tiffany Wong, MD,

Alexis J. Carimi, MD, Kelly L. Paulk, MD, Matthew Bloom, DO,

Brandon L. Hicks, MD, Sarah E. Clevenger, MD, John L. Faciane, MD,

Jonathan H. Greenwald, DO

Disclosures:

Marc Raj: I Have No Relevant Financial Relationships To

Disclose

Objective:

To determine the risk factors associated with increased

probability for DVT at the time of admission to in-patient rehabilita-

tion in patients with traumatic spinal cord injuries and to establish

cost effective screening protocols.

Design:

Retrospective chart review.

Setting:

Inpatient rehabilitation hospital.

Participants:

154 patients with traumatic spinal cord injuries.

Interventions:

Venous Compression Ultrasound with Doppler of lower

extremities

Main Outcome Measures:

A chart review was performed doc-

umenting; age, sex, BMI, neurological level of injury, ASIA score,

result of Doppler at time of admission, use of prophylactic anti-

coagulation(if so which), length of time on acute, lower extremity

fracture, spine surgery, and ambulatory status at time of admission.

Patients with known history of malignancy, history of DVT/PE, or on

anticoagulation for other medical issues were excluded.

Results:

18/154(11.7%) patients were positive for DVT at time of

admission. Out of 154 patients, n

¼

12 were on no chemical prophylaxis

(3/12 [25%] positive for DVT), n

¼

5 on Heparin 5000 units bid (1/5[20%]

positive for DVT), n

¼

24 on Heparin 5000 units TID (1/24[4.2%] positive for

DVT), n

¼

68 on Enoxaparin 40mg qd (8/68[11.8%] positive for DVT), n

¼

9

on Enoxaparin 30mg bid (3/9 [33.3%] positive for DVT), n

¼

26 patients

were on novel anticoagulants (2/26 [7.6%] were positive for DVT), n

¼

10

were unknown. n

¼

83with C spine injuries. 9/83 (10.8%) were positive for

DVT. n

¼

40 with T1-T10 spine injuries. 3/40 (7.5%) were positive for DVT.

n

¼

31 with T11-L5 spine injures. 6/31 (19.4%) were positive for DVT.

6/21(28.6%) Patients with T11-L5 ASIA A or B were positive for DVT. There

was no correlation between age, sex, race, BMI, spine surgery, lower

extremity fracture, or time on acute and DVT.

Conclusions:

It may be practical to screen: 1. T11-L5 paraplegic pa-

tients with ASIA score of A and B. 2. Patients who were on chemical

prophylaxis other than Enoxaparin 40mg qd, heparin 5000 units TID, or

novel anticoagulants. 3. Patients on no chemical prophylaxis.

Level of Evidence:

Level II

S289

Abstracts / PM R 9 (2017) S131-S290